About
Acquisition of products
Areas of Focus
Categories
Biologics & BiopharmaceuticalSmall Molecule PharmaceuticalBoston & New England
Clinical Trials (14)
View allTotal Trials
14
As Lead Sponsor
13
As Collaborator
1
Total Enrollment
953
By Phase
PHASE2: 4PHASE1: 8PHASE1/PHASE2: 1
By Status
COMPLETED: 12RECRUITING: 1ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline13 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT06920043Lead Sponsor
A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH
PHASE2Recruiting
42 participants
Started: Apr 9, 2025 · Completed: Dec 31, 2027
NCT04880031Lead Sponsor
A Study of BOS-580 in Obese Subjects at Risk for, or With Biopsy-confirmed, Nonalcoholic Steatohepatitis (NASH) With an Extension
PHASE2Active, not recruiting
231 participants
Started: Sep 30, 2021 · Completed: Nov 30, 2025
NCT04221906Lead Sponsor
Study to Evaluate the Safety and Antipsoriatic Efficacy of BOS-475 in a Psoriasis Plaque Test
PHASE1Completed
15 participants
Started: Jan 6, 2020 · Completed: Mar 6, 2020
NCT04163263Lead Sponsor
Study to Evaluate the Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Effects of Repeat Topical Application of BOS-356 in Subjects With Moderate to Severe Acne Vulgaris
PHASE1Completed
66 participants
Started: Nov 4, 2019 · Completed: Nov 11, 2020
NCT04514237Lead Sponsor
Study to Determine the Relative Bioavailability, Single and Repeat Dose Pharmacokinetics, Safety and Tolerability of BOS172767 Enantiomers in Healthy Subjects
PHASE1Completed
12 participants
Started: Sep 12, 2019 · Completed: Jan 22, 2020
Locations (1)
Headquarters
Cambridge, MA, United States
Map
Loading map...